171 related articles for article (PubMed ID: 27242669)
1. Which Is the Ideal Treatment for Benign Diffuse and Multinodular Non-Toxic Goiters?
Knobel M
Front Endocrinol (Lausanne); 2016; 7():48. PubMed ID: 27242669
[TBL] [Abstract][Full Text] [Related]
2. Evaluation and management of multinodular goiter.
Hurley DL; Gharib H
Otolaryngol Clin North Am; 1996 Aug; 29(4):527-40. PubMed ID: 8844728
[TBL] [Abstract][Full Text] [Related]
3. Levothyroxine suppressive therapy is partially effective in treating patients with benign, solid thyroid nodules and multinodular goiters.
Lima N; Knobel M; Cavaliere H; Sztejnsznajd C; Tomimori E; Medeiros-Neto G
Thyroid; 1997 Oct; 7(5):691-7. PubMed ID: 9349571
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human TSH and radioactive iodine therapy in the management of benign multinodular goiter.
Graf H
Eur J Endocrinol; 2015 Feb; 172(2):R47-52. PubMed ID: 25189867
[TBL] [Abstract][Full Text] [Related]
5. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma.
Tonacchera M; Chiovato L; Pinchera A; Agretti P; Fiore E; Cetani F; Rocchi R; Viacava P; Miccoli P; Vitti P
J Clin Endocrinol Metab; 1998 Feb; 83(2):492-8. PubMed ID: 9467563
[TBL] [Abstract][Full Text] [Related]
6. Time to reconsider nonsurgical therapy of benign non-toxic multinodular goitre: focus on recombinant human TSH augmented radioiodine therapy.
Fast S; Nielsen VE; Bonnema SJ; Hegedüs L
Eur J Endocrinol; 2009 Apr; 160(4):517-28. PubMed ID: 19106244
[TBL] [Abstract][Full Text] [Related]
7. Radioiodine therapy for multinodular goiter.
Iglesias Bolaños P; Pavón de Paz I; Díaz Guardiola P; Guijarro de Armas G; Javier Penín González F; Peña RE
Endocrinol Nutr; 2008 Jun; 55(6):263-6. PubMed ID: 22964127
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune hyperthyroidism occurring late after radioiodine treatment for volume reduction of large multinodular goiters.
Huysmans AK; Hermus RM; Edelbroek MA; Tjabbes T; Oostdijk ; Ross HA; Corstens FH; Kloppenborg PW
Thyroid; 1997 Aug; 7(4):535-9. PubMed ID: 9292939
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and management of large toxic multinodular goiters.
Hamburger JI; Hamburger SW
J Nucl Med; 1985 Aug; 26(8):888-92. PubMed ID: 2411889
[TBL] [Abstract][Full Text] [Related]
10. Approach to the patient with nontoxic multinodular goiter.
Bahn RS; Castro MR
J Clin Endocrinol Metab; 2011 May; 96(5):1202-12. PubMed ID: 21543434
[TBL] [Abstract][Full Text] [Related]
11. Increased lipid peroxidation and impaired enzymatic antioxidant defense mechanism in thyroid tissue with multinodular goiter and papillary carcinoma.
Erdamar H; Cimen B; Gülcemal H; Saraymen R; Yerer B; Demirci H
Clin Biochem; 2010 May; 43(7-8):650-4. PubMed ID: 20171198
[TBL] [Abstract][Full Text] [Related]
12. A 30-year perspective on radioiodine therapy of benign nontoxic multinodular goiter.
Bonnema SJ; Hegedüs L
Curr Opin Endocrinol Diabetes Obes; 2009 Oct; 16(5):379-84. PubMed ID: 19623060
[TBL] [Abstract][Full Text] [Related]
13. [Indications and procedures in conservative goiter treatment].
Bürgi H
Helv Chir Acta; 1978 Jan; 44(5-6):709-18. PubMed ID: 624638
[TBL] [Abstract][Full Text] [Related]
14. Approach to and treatment of goiters.
Medeiros-Neto G; Camargo RY; Tomimori EK
Med Clin North Am; 2012 Mar; 96(2):351-68. PubMed ID: 22443980
[TBL] [Abstract][Full Text] [Related]
15. [The use for recombinant human TSH in patients with toxic and non-toxic nodular goiter].
Jedrzejuk D; Milewicz A
Postepy Hig Med Dosw (Online); 2005 May; 59():188-92. PubMed ID: 15928602
[TBL] [Abstract][Full Text] [Related]
16. Surgical excision of large multinodular goiter using an endoscopic transaxillary approach: a case report.
Duncan TD; Rashid QN; Speights F
Surg Laparosc Endosc Percutan Tech; 2008 Oct; 18(5):530-5. PubMed ID: 18936685
[TBL] [Abstract][Full Text] [Related]
17. Postintervention serum TSH levels may be useful to differentiate patients who should undergo levothyroxine suppressive therapy after thyroid surgery for multinodular goiter in a region with moderate iodine deficiency.
Rotondi M; Amato G; Del Buono A; Mazziotti G; Manganella G; Biondi B; Sinisi AM; Santini L; Bellastella A; Carella C
Thyroid; 2000 Dec; 10(12):1081-5. PubMed ID: 11201853
[TBL] [Abstract][Full Text] [Related]
18. [Large goiter--diagnosis and treatment].
Heck A; Cappelen T; Følling I
Tidsskr Nor Laegeforen; 2007 May; 127(9):1196-200. PubMed ID: 17479138
[TBL] [Abstract][Full Text] [Related]
19. Radioiodine therapy of benign non-toxic goitre. Potential role of recombinant human TSH.
Fast S; Bonnema SJ; Hegedüs L
Ann Endocrinol (Paris); 2011 Apr; 72(2):129-35. PubMed ID: 21513911
[TBL] [Abstract][Full Text] [Related]
20. Rationale for the operative management of substernal goiters.
Allo MD; Thompson NW
Surgery; 1983 Dec; 94(6):969-77. PubMed ID: 6648812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
